369 related articles for article (PubMed ID: 35933332)
1. Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
Nascimento NPG; Gally TB; Borges GF; Campos LCG; Kaneto CM
BMC Cancer; 2022 Aug; 22(1):862. PubMed ID: 35933332
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
3. Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
Ocadiz-Delgado R; Lizcano-Meneses S; Trejo-Vazquez JA; Conde-Perezprina JC; Garrido-Palmas F; Alvarez-Rios E; García-Villa E; Ruiz G; Illades-Aguiar B; Leyva-Vázquez MA; García-Carrancá A; Gariglio P
APMIS; 2021 Feb; 129(2):70-79. PubMed ID: 33112434
[TBL] [Abstract][Full Text] [Related]
4. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
5. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.
Aftab M; Poojary SS; Seshan V; Kumar S; Agarwal P; Tandon S; Zutshi V; Das BC
Sci Rep; 2021 May; 11(1):10323. PubMed ID: 33990639
[TBL] [Abstract][Full Text] [Related]
6. A Novel Circulating MiRNA-Based Signature for the Diagnosis and Prognosis Prediction of Early-Stage Cervical Cancer.
Qiu H; Liang D; Liu L; Xiang Q; Yi Z; Ji Y
Technol Cancer Res Treat; 2020; 19():1533033820970667. PubMed ID: 33327867
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of miRNAs for the detection of cervical cancer.
Hillyar CR; Kanabar SS; Pufal KR; Saw Hee JL; Lawson AW; Mohamed Y; Jasim D; Reed L; Rallis KS; Nibber A
Epigenomics; 2023 May; 15(10):593-613. PubMed ID: 37535320
[TBL] [Abstract][Full Text] [Related]
8. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
9. Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia.
Kawai S; Fujii T; Kukimoto I; Yamada H; Yamamoto N; Kuroda M; Otani S; Ichikawa R; Nishio E; Torii Y; Iwata A
Sci Rep; 2018 May; 8(1):7070. PubMed ID: 29728572
[TBL] [Abstract][Full Text] [Related]
10. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
[TBL] [Abstract][Full Text] [Related]
11. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
12. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
13. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
15. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer.
Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A
J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
18. HPV16
Pulati N; Zhang Z; Gulimilamu A; Qi X; Yang J
J Gene Med; 2019 Nov; 21(11):e3126. PubMed ID: 31498525
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
[TBL] [Abstract][Full Text] [Related]
20. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]